Table 2 Clinical outcomes of patients with an LVAD
No | 1 | 2 | 3 | 4 | Bishop et al. [9] | Ryan et al. [10] |
|---|---|---|---|---|---|---|
TTR (%) | 88.6 | 92.2 | 89.6 | 90.1 | 44.4 | 74.0 |
Overall PT-INR, mean ± SD | 2.01 ± 0.30 | 1.87 ± 0.21 | 1.92 ± 0.22 | 2.47 ± 0.50 | 2.32 ± 0.67 | – |
Overall warfarin dose, mean ± SD | 4.49 ± 0.76 | 5.13 ± 0.58 | 3.30 ± 0.34 | 3.24 ± 0.33 | – | – |
Major bleeding events | ||||||
GI bleeding events | no | no | no | no | yes (2/11) | no |
LVAD site bleeding events | no | no | no | no | no | no |
Other bleeding events | no | no | no | no | no | no |
All thrombosis events | ||||||
Pump thrombosis events | no | no | no | no | no | no |
Other thrombosis events | no | no | no | no | yesa (1/11) | yesb (2/162) |
LVAD-related infections | no | yes | yes | no | – | – |
Heart transplants received | no | yes | no | no | yes (1/11) | – |